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Abstract: We investigated TLR10 expression in human monocytes, THP-1 cells, cultured 
in hypoxia (3% O2). Levels of both TLR10 mRNA and protein in THP-1 cells cultured in 
hypoxia were significantly higher than those cultured in normoxia (20% O2). We examined 
intracellular  reactive  oxygen  species  (ROS)  content  in  hypoxic  cells,  and  TLR10 
expression  in  cells  treated  with  hydrogen  peroxide  (H2O2),  to  determine  whether  the 
increase in TLR10 expression observed with hypoxia was due to an increase in intracellular 
ROS levels. We found that the level of intracellular ROS in cells subject to hypoxia was 
significantly higher than in normoxia. Experiments with ROS synthesis inhibitors revealed 
that hypoxia induced ROS production is mainly due to NADPH oxidase activity. TLR10 
mRNA expression was increased by treatment with H2O2 at concentrations ranging from 50 
to  250  μM.  We  screened  the  TLR10  promoter  and  found  putative  binding  sites  for 
transcription  factors  (TFs),  such  as  NF-κB,  NF-AT  and  AP-1.  Next,  we  examined  TF 
activities using a luciferase reporter assay. Activities of NF-κB, NF-AT and AP-1 in the 
cells treated with H2O2 were significantly higher than in untreated cells. The experiment 
with TF inhibitors revealed that ROS-induced upregulation of TLR10 expression is mainly 
due to NF-κB activation. Overall, our results suggest that hypoxia or ROS increase TLR10 
expression in human monocytes and the transcriptional activities of NF-κB are involved in 
this process. Therefore, it is suggested that ROS produced by various exogenous stimuli 




may play a crucial role in the regulation of expression and function of TLR10 as second 
messengers. 
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1. Introduction 
Toll-like receptors (TLRs), a major class of pathogen recognition receptor, play a crucial role in the 
induction of innate immunity at the early stage of infection and also in subsequent recruitment of 
adaptive immunity [1]. When TLRs located on the cell surfaces or in endosomes recognize pathogen 
associated molecular patterns (PAMPs), the Toll/interleukin-1 receptor (TIR) domain interacts with 
myeloid  differentiation  factor  88  (MyD88),  common  TIR  adaptor.  This  interaction  leads  to  the 
activation of a downstream signaling pathway and ultimately induces the expression of inflammatory 
genes via transcriptions factors (TFs) NF-κB or IRF [2]. 
In mammals, 13 TLRs have been identified which can recognize many structurally different ligands 
through their distinct extra-domain [3]. In humans, 10 TLRs have been found and their ligands have 
also  been  identified  except  for  in  the  case  of  TLR10  [2].  Like  other  TLRs,  TLR10  has  multiple 
leucine-rich repeats and TIR domain and TLR10 shares the highest homology with TLR1 and TLR6 
[4]. TLR10 can form either a homodimer or a heterodimer with TLR1 or TLR2 and like other TLRs, it 
transmits an intracellular signal via MyD88 [5]. A recent structural study showed that two TLR10-TIR 
domain complexes can form a dimer [6]. 
Local hypoxic conditions can be developed in various inflamed, infected, and diseased tissues due 
to occlusion of the local blood supply or the inability of local vessel growth to keep pace with the 
growth and/or infiltration of cells in the affected tissue [7]. In these conditions, macrophages not only 
increase  intracellular  levels  of  H2O2  but  also  up-regulate  the  expression  of  genes  required  for 
macrophage  survival,  angiogenesis,  and  recruitment  and  activation  of  macrophages  and/or  other 
inflammatory cells [7]. 
Regarding the regulation of TLR expression, it has been reported that hypoxia increases TLR4 
expression in human microglia [8] and murine macrophages [9]. Another study showed that hypoxia 
selectively increased the expressions of TLR2 and TLR6 in murine and human dendritic cells (DCs) 
[10]. Although not a direct effect of hypoxia, LPS-induced intracellular reactive oxygen species (ROS) 
production was found to increase TLR4 expression in THP-1 cells [11]. 
So far, there has been no report of effects of hypoxia or ROS on TLR10 expression except one 
previous  account  which  stated  that  hypoxia  does  not  affect  TLR10  expression  in  human  DCs, 
microvascular epithelial cell lines and CaCo-2 cells [10]. In this study, we therefore attempted to 
examine the effects of hypoxia and ROS on TLR10 expression in human monocytes THP-1. 




2. Results and Discussion 
2.1. Hypoxia Enhanced Intracellular ROS Production and TLR10 Expression in THP-1 Cells 
TLR10 expression in human monocytes THP-1 cells cultured in hypoxic conditions (3% O2) was 
investigated. Levels of TLR10 mRNA expression in THP-1 cells cultured for 1 to 5 days in hypoxia 
were higher than those in normoxia (20% O2) (Figure 1A). The level of surface TLR10 expression of 
cells  in  hypoxia  was  also  higher  than  those  in  normoxia  (Figure  1B).  Since  hypoxia  increases 
intracellular ROS [12,13], and ROS play a role in regulation of gene expression [13,14], we examined 
intracellular ROS content to determine whether TLR10 expression levels correlated with intracellular 
ROS  levels.  Intracellular  ROS  content  in  THP-1  cells  in  hypoxia  gradually  increased  during  the 
cultivation period and was approximately three times higher than in normoxia at day 4 (Figure 2).  
There are several sources of ROS in monocytes, including NADPH oxidase, xanthine oxidase and 
mitochondria [15]. To examine which enzyme systems are involved in ROS generation in hypoxic 
condition and whether ROS are directly involved in up-regulation of TLR10 expression, we used three 
different ROS synthesis inhibitors; TTFA, mitochondria electron transport chain complex II inhibitor; 
Apocynin, NADPH oxidase inhibitor; Allopurinol, xanthine oxidase inhibitor. All three inhibitors were 
found to be capable of inhibiting intracellular ROS generation in hypoxic conditions (Figure 3A). 
However,  NADPH  oxidase  inhibitor  was  found  to  be  only  potent  to  inhibit  the  TLR10  mRNA 
expression (Figure 3B). These results indicate that the main enzyme corresponding to the hypoxia-
induced up-regulation of TLR10 expression is NADPH oxidase. 
Figure 1. Hypoxia upregulated TLR10 expression in THP-1 cells. (A) A representative 
RT-PCR  showing  time  course  expression  of  TLR10  mRNA  in  THP-1  cells  grown  in  
3% O2 for 5 days. The relative expression of TLR10 mRNA was normalized by GAPDH 
using densitometric analysis; (B) Surface TLR10 expression of THP-1 cells grown in 20% 
or 3% O2 for 3 days was examined by FACS analysis. *P < 0.05. 
 




Figure  2.  Hypoxia  generated  intracellular  ROS  in  THP-1  cells.  (A)  Representative 
fluorescence  microscopic  images  showing  the  fluorescence  of  DCF  oxidized  by 
intracellular ROS in THP-1 cells grown in 20% or 3% O2 for 5 days. After cultivation, the 
cells  were  incubated  with  10  μM  DCFH-DA  for  15  min  at  37  °C   and  assessed  by 
fluorescence microscopy; (B) Normalized mean fluorescence intensities (MFI) of DCF in 
THP-1 cells grown in 3% O2 for 1–5 days were examined by FACS analysis.  
 
Figure 3. NADPH oxidase inhibitor suppressed intracellular ROS production and TLR10 
mRNA expression in THP-1 cells cultured in hypoxia. (A) Intracellular ROS production 
was examined in THP-1 cells grown in 3% O2 for 2 days in the presence of three different 
ROS  synthesis  inhibitors;  Apocynin (Apo, 100 μM), NADPH oxidase inhibitor;  TTFA 
(100 μM), mitochondria electron transport chain complex II inhibitor; Allopurinol (Allo, 
100  μM),  xanthine  oxidase  inhibitor.  After  cultivation,  the  cells  were  incubated  with 
10 μM  DCFH-DA  for  15  min  at  37  °C   and  assessed  by  FACS  analysis;  (B)  A 
representative RT-PCR data showing TLR10 expression in THP-1 cells treated with ROS 
synthesis inhibitor. The cells grown in 3% O2 for 3 days in the presence or absence of three 
different ROS synthesis inhibitors were harvested and examined by RT-PCR analysis. The 
relative expression of TLR10 was normalized by GAPDH using densitometric analysis. *P 
< 0.05, **P < 0.01. 
 
2.2. Hydrogen Peroxide Enhanced TLR10 Expression in THP-1 Cells in a Concentration- and  
Time-Dependent Manner 
Since the levels of intracellular ROS and TLR10 expression were found to be increased in cells in 




the  most  stable  and  longest  lived  among  ROS  [16,17]  and  is  considered  an  intracellular  second 
messenger as well as an intercellular messenger [18–20], we selected H2O2 to treat cells to examine the 
effect of ROS on TLR10 expression in THP-1 cells. Treatment of the cells with H2O2 at concentrations 
ranging from 50 to 250 μM significantly enhanced TLR10 mRNA expression (Figure 4). Figure 5A 
shows the time course of TLR10 mRNA expression in response to 100 μM H2O2. Expression increased 
10 min after incubation and returned to the original level after 1 h. The increase in surface expression 
was also paralleled by an increase in mRNA level as a function of incubation time (Figure 5B). 
Figure  4.  TLR10  mRNA  expression  in  THP-1  cells  in  the  presence  of  varying 
concentrations of ROS. A representative RT-PCR experiment showing TLR10 expression 
in THP-1 cells treated with H2O2. The cells that had been maintained at 37 °C  in 20% O2 
were treated with varying concentrations of H2O2 for 1 h and then the cells were harvested 
and examined by RT-PCR analysis. The relative expression of TLR10 was normalized by 
GAPDH using densitometric analysis. 
 
Figure 5. TLR10 expression in THP-1 cells as a function of various incubation times of 
ROS. (A) A representative RT-PCR experiment showing TLR10 expression in THP-1 cells 
treated with 100 μM H2O2. The cells that had been maintained at 37 °C  in 20% O2 were 
treated with 100 μM H2O2 for 0 to 6 h as indicated below and then the cells were harvested 
and examined by RT-PCR analysis; (B) Surface TLR10 expression of THP-1 cells treated 
with 100 μM H2O2. The cells that had been maintained at 37 °C  in 20% O2 were treated 
with 100 μM H2O2 for 0 to 4 h as indicated below and then the cells were harvested and 


















2.3. NF-κB Inhibitor Suppressed H2O2-Induced TLR10 Up-Regulation 
To determine whether TFs, such as NF-κB, NF-AT and AP-1, which can be activated in response to 
various stresses [21], are involved in the increase in TLR10 mRNA expression by H2O2, we screened 
the TLR10 promoter to identify putative binding sites for TFs using a binding site prediction program. 
The total numbers of conserved binding sites for NF-κB, NF-AT and AP-1 within the TLR10 promoter 
region (defined as 1000 bp upstream of the transcription start site) were 1, 9, and 1, respectively 
(Figure  6).  The  luciferase-reporter  assay  revealed  that  treatment  of  the  cells  with  100  μM  H2O2 
enhanced the activities of NF-κB, NF-AT, and AP-1 (Table 1). To examine which TFs are involved in 
ROS-induced up-regulation of TLR10 expression, we used three different TF inhibitors. As shown in 
Figure 7, NF-κB inhibitor significantly inhibited the H2O2-induced up-regulation of TLR10 mRNA 
expression but other inhibitors did not. Therefore, the increase in TLR10 expression of THP-1 cells by 
H2O2 seems to be mainly due to NF-κB activation. Since hypoxia-inducible factor (HIF-1) has been 
known to play a central role in regulation of cellular responses to hypoxia [22,23] and in regulation of 
the innate immune function of phagocytes [24], we examined the possible involvement of HIF-1 in the 
increase in TLR10 mRNA expression. An HIF-1 binding site search revealed no binding site up to 
3000 bp upstream of the transcription start site. Expression levels of HIF-1α mRNA in cells treated 
with 100 μM H2O2 were not changed (Figure 8). 
Figure 6. Summary of computer assisted search for the putative binding sites for selected 
TFs. The putative binding sites were predicted by using Alggen Promo software, V 3.0.2 
(http://alggen.lsi.upc.es). Factor name—transcription factor with its TRANSFAC (V 8.3) 
database accession number; Start and End—start and end positions of putative binding 
sequences, respectively; Dissimilarity—rate of dissimilarity (%) between the putative and 
consensus  sequences;  String—nucleotide  sequence  of  potential  binding  site;  Random 
Expectation  (RE)—expected  occurrences  of  the  match  in  a  random  sequence  
of  the  same  length  as  the  query  sequence  according  to  the  dissimilarity  index  
(RE  equally—equi–probability  for  the  four  nucleotides  and  RE  query—nucleotide 
frequencies as in the query sequence).  




Table 1. Effects of ROS on activities of TFs, NF-κB, AP-1 and NF-AT. The data are 
expressed as fold change in luciferase activity of cells treated with 100 μM H2O2 versus 
untreated cells. Cells at a density of 1 ×  10
5 cells/well were treated with 100 μM H2O2 for  
6  h.  For  positive  control,  cells  were  treated  with  20  ng/mL  of  TNF-α  (for  NF-κB),  
20 ng/mL of PMA (for AP-1), or 10 ng/mL of PMA and 1 μg/mL of ionomycin (for  
NF-AT) for 6 h. After the stimulation, harvested cells were used for luciferase assay as 
described in Materials and Methods. *P < 0.05, **P < 0.01, ***P < 0.005. 
Transcription 
Factors 
Relative Luciferase Activity (Fold) 
ROS Treated  Positive Control 
NF-B  1.46  0.45*  5.12  1.52*** 
AP-1  1.32  0.26**  18.37  3.79*** 
NF-AT  1.21  0.13***  3.04  0.90*** 
Figure 7. NFB inhibitor suppressed H2O2-induced up-regulation of TLR10 expression. 
A representative RT-PCR data showing TLR10 expression in THP-1 cells were treated 
with TF inhibitors for 30 min or 1 h before treatment with 100 μM H2O2. AP-1, NF-AT 
and NF-B were blocked with curcumin (Sigma, 10 μM, preincubation for 30 min), a 
cell-permeable  NF-AT  inhibitor  peptide  (Calbiochem,  4  μM,  for  1  h)  and  quinazoline 
(Enzo  Life  Sciences  Inc.,  10  μM,  for  30  min),  respectively.  The  cells  that  had  been 
maintained at 37 ° C in 20% O2 in the presence or absence of the inhibitors were treated 
with 100 μM H2O2 for 1 h, harvested and then examined by RT-PCR analysis. The relative 
expression of TLR10 was normalized by GAPDH using densitometric analysis. *P < 0.05. 




Figure 8. HIF-1 mRNA expression in THP-1 cells as a function of various incubation 
times of ROS. A representative RT-PCR experiment showing HIF-1α expression in THP-1 
cells treated with 100 μM H2O2. The cells that had been maintained at 37 °C  in 20% O2 
were treated with 100 μM H2O2 for 0 to 2 h as indicated below and then the cells were 







To  our  knowledge,  this  is  the  first  study  demonstrating  up-regulation  of  TLR10  expression  in 
human monocytes cultured in hypoxia or in the presence of H2O2. TLR10 is the only orphan receptor 
among the human TLRs. One major hindrance to TLR10 study is the absence of its mouse homologue. 
Therefore,  studying  the  expression  of  TLR10  in  human  immune  cells  is  essential.  Changes  of 
expression patterns in response to certain stimuli may help us predict its possible ligand(s). TLR10 
expression has been known to be mainly restricted to B cells and plasmacytoid DCs [2,5]. However, 
the  present  study  showed  TLR10  expression  in  human  monocytic  cell  line,  THP-1  which  is  in 
agreement with a previous report [4]. We also found surface expression of TLR10 in human primary 
monocytes (data not shown).  
Although a natural ligand for TLR10 has not been identified so far, structural or functional studies 
have  suggested,  that  like  other  TLRs,  it  can  transfer  intracellular  activation  signals  through 
MyD88 [5,6]. In addition, a study on TLR10 polymorphism with asthmatic patients suggested that 
TLR10 may be involved in the recognition of airborne pathogens or airborne allergens [25]. It has also 
been reported that some haplotype of TLR10 is associated with increase in the risk of nasopharyngeal 
carcinoma [26]. In mammals, TLR1, 6, and 10 genes are tandemly arranged and seem to have arisen 
from duplication event [27,28]. Studies on single nucleotide polymorphisms in the TLR1-6-10 gene 
cluster have suggested that mutations within this cluster may be associated with a risk of asthma [25], 
prostate cancer [29] or non-Hodgkin lymphoma [30]. 
Macrophages play a critical role in certain circumstances such as bacterial infection, tissue injury, 
inflammatory disease, and tumor formation. The genes that are up-regulated in these circumstances 
largely overlap with those in hypoxia, which inevitably develops in these circumstances [7]. Based on 
this relationship, we speculate that TLR10, whose expression level in THP-1 cells was found to be 
enhanced by hypoxia, may play a role in immune responses of human monocytes to bacterial infection, 
tissue injury, inflammatory disease, and tumor formation. 
When cells are exposed to hypoxic conditions they produce and use ROS as second messengers in 




expressions of various genes [7]. Genes that are increased by hypoxia mainly include those involved in 
cell  survival,  angiogenesis,  and  activation  and  recruitment  of  leukocytes,  including  macrophages 
themselves  [7].  ROS  can  be  produced  by  pro-inflammatory  stimuli  including  TNF-α,  IL-1β,  and  
LPS [31,32]. In turn, ROS can induce inflammatory responses via NF-κB or AP-1 activation [33]. It 
has been well known that hypoxia [34] and ROS [35] play a role in the activation of NF-κB, AP-1, and 
HIF-1 that contribute to gene regulation in inflammation. Intermittent hypoxia has been shown to 
activate NF-AT as well as NF-κB, AP-1, and HIF-1 [36]. The present study revealed that the existence 
of the putative binding site for NF-κB within the TLR10 promoter region, the activation of NF-κB by 
H2O2  and  suppression  of  H2O2-induced  up-regulation  of  TLR10  expression  by  NF-κB  inhibitor. 
Considering these results combined with those of previous studies addressing the direct correlation 
between hypoxia and ROS and the activities of NF-κB, the increases in TLR10 expression of THP-1 
cells by hypoxia or exogenous H2O2 seem to be directly associated with activation of NF-κB. 
In hypoxic conditions, HIF plays a major role in TNF and NO production by macrophages [37] and 
phagocytosis of macrophages [38]. HIF-responsive elements have been known to be located in TLR2 
and TLR6 genes and the expression levels of both genes increases in hypoxia in a HIF-1α dependent 
manner  [10].  In  the  present  study,  however,  no  HIF-1  binding  site  was  found  within  the  TLR10 
promoter region; therefore, it seems that HIF-1 may not be directly associated with the increase in 
TLR10 expression by hypoxia or ROS.  
3. Experimental Section 
3.1. Reagents 
Apocynin (Apo) as an NADPH oxidase inhibitor, allopuronil (Allo) as a xantin oxidase inhibitor,  
TTFA (2-Thenoyltrifluoroacetone) as a mitochondria electron transport chain complex II inhibitor and 
hydrogen  peroxide  (H2O2)  were  purchased  from  Sigma  Aldrich  Corp.  (Sat.  Louis,  Mo,  U.S.). 
Curcumin  as  curcuminoid,  NF-κB  activation  inhibitor  (6-Amino-4-(4-phenoxyphenylethylamino) 
quinazoline) and NF-AT Inhibitor were purchased from Sigma, Enzo Life Sciences Inc. (Plymouth 
Meeting, PA, U.S.) and Calbiochem/EMD Biosciences (San Diego, CA, U.S.), respectively.  
3.2. Cell Culture 
The Human monocytic cell line THP-1 cells were obtained from KCLB (Korean cell line bank, 
Seoul,  Korea)  and  cultured  in  RPMI  1640  (Welgene,  Daegu,  Korea)  supplemented  with  10%  
heat-inactivated  fetal  bovine  serum  (FBS,  Lonza,  Basel,  Switzerland),  1%  Antibiotic-Antimycotic 
(Invitrogen, Gibco BRL, MD, U.S.), 10 mM HEPES buffer (Invitrogen), 50 μM 2-mercaptoethanol 
(Invitrogen), THP-1 cells were maintained at 37 °C  under 5% CO2 in 95% air (20% O2). For the low 
oxygen experiment, cells were maintained in Heracell gas addition incubator (Heraeus Instruments 
GmbH, Hanau, Germany) with gas mixtures consisting of 3% O2, 5% CO2, and 92% N2 (referred to as 
3% O2). To measure effects of ROS synthesis inhibitors on the intracellular ROS production in THP-1 
cells, we used Apo (100 μM), TTFA (100 μM) or Allo (100 μM). Cells were pretreated with each 
inhibitor for 30 min before cultivation under 3% O2. After 48 h-incubation, intracellular ROS level was 




mentioned above, TLR10 expression was examined by RT-PCR analysis. To measure effects of TF 
inhibitors on H2O2-inducted up-regulation of TLR10 expression in THP-1 cells, 10 μM curcumin (for 
AP-1), 10 μM QNZ (for NF-κB) were pretreated for 30 min and 4 μM NF-AT inhibitor was pretreated 
for 1 h before H2O2 treatment. After 1 h incubation with H2O2, cells were harvested and TLR10 
expression was examined by RT-PCR analysis. 
3.3. RT-PCR 
Total RNA was isolated using the Qiagen RNAeasy kit according to the manufacturer’s instructions 
(QIAGEN).  The  concentration  and  purity  of  the  RNA  were  determined  by  OD260/280  reading.  
The  cDNA  was  synthesized  from  2  μg  of  total  RNA  with  SuperScript  III  Reverse  
Transcriptase  (Invitrogen)  using  an  Oligo  (dT)  primer  (Invitrogen)  at  50  °C   for  1  h.  PCR  
amplification  was  performed  using  following  primer  sets:  TLR10  5'-ctgggacgaccttttccttatct-3',  
5'-cagagatgggctgagaatgaagt-3', GAPDH 5'-acagcctcaagatcatcagcaat-3', 5'-aggaaatgagcttgacaaagtgg-3', 
HIF-1α 5'-gtctcgagatgcagccagatctcg-3',  5'-ggtcagatgatcagagtccaaagc-3'.  Thermocycling  conditions 
were 30 sec at 94 °C , 30 sec at 58 °C , and 30 sec at 72 °C  for 28–35 cycles preceded by 10 min at 
94 °C . PCR products were fractionated by 1.5% agarose gel electrophoresis, stained with ethidium 
bromide, and visualized with UV light. The bands were quantitated by densitometric analysis using 
KODAK MI software (Rochester, NY, U.S.). 
3.4. Measurement of Reactive Oxygen Species 
Inside cells, DCFH-DA was cleaved by esterases forming DCFH, which was in non-fluorescent 
form and was oxidized to fluorescent compound DCF by ROS. Following exposure to 20% or 3% O2 
for 1–5 days, cells were loaded with 10 μM DCFH-DA for 15 min at 37 °C  and viewed under the 
fluorescence  microscope.  ROS  measurement  was  carried  out  on  FACS  flow  cytometer  (Beckman 
Coulter, Fullerton, CA, U.S.).  
3.5. Flow Cytometric Analysis  
Fluorescence-activated  cell  sorter  (FACS)  analysis  was  performed  to  determine  the  monocyte 
surface expression of TLR10. Following exposure to 20% or 3% O2 for 3 days or 100 μM H2O2 for  
0 to 4 h at 20% O2, THP-1 cells were harvested and washed twice, and stained with PE-conjugated 
anti-human TLR10 mAb (IMG-386D, Imgenex, San Diego, CA, U.S.) for 30 min at 4 °C  in PBS. Cells 
were washed and resuspended in PBS, and analyzed on a FACS flow cytometer (Beckman Coulter).  
3.6. Prediction of TF Binding Sites  
To identify putative binding sites for NF-κB, AP-1, NF-AT and HIF-1 within the TLR10 promoter 
region,  the  TF  binding  site  prediction  program  [39]  Alggen  Promo  software,  V3.0.2 




3.7. Luciferase Reporter Gene Assay 
THP-1 (1 ×  10
6) suspended in 10 mL RPMI-1640 medium were seeded in 25 cm
2 T-flask. After 
incubating at 37 °C  for 24 h, the cells were transiently transfected with 1 μg of luciferase reporter 
plasmids  (pNF-κB-Luc,  pAP-1-Luc  or  pNF-AT-luc)  and  1  μg  of  pCMV-βGal  using  Nucleofector 
technology  (Nucleofector  II,  Amaxa,  Cologne,  Germany).  Cells  were  resuspended  in  100 μL 
Nucleofector Solution V (Amaxa) and nucleofected with plasmids using program V-001. Following 
nucleofection, the cells were incubated in prewarmed RPMI 1640 medium for 4 h and then fresh 
complete medium was added. After 24 h, the cells were harvested, seeded in 24-well plates at a density 
of 1 ×  10
5 cells/well and treated with 100 μM H2O2 (Sigma Aldrich Corp., Sat. Louis, Mo, U.S.) for  
6 h. For a positive control, cells were treated with 20 ng/mL of TNF-α (for NF-κB, eBioscience, San 
Diego, CA, U.S.), 20 ng/mL  of PMA (for AP-1, Sigma), or 10 ng/mL  of PMA and 1 μg/mL of 
ionomycin (for NF-AT, Sigma) for 6 h. After the stimulation, cells were harvested, washed and used 
for  luciferase  assay.  Luciferase  activity  and  β-galactosidase  activity  were  assayed  by  using  the 
luciferase and β-galactosidase enzyme assay system (Promega, Madison, WI, U.S.). The luminescence 
was  quantitated  as  a  relative  light  unit  on  a  luminometer  (Sirius  luminometer,  Berthold  detection 
system GmbH, Germany). The results are expressed as relative reporter gene activity compared with 
controls after normalizing β-galactosidase activity.  
3.8. Statistical Analysis 
Student’s t tests were performed using statistical software SPSS 12.0. All data are mean ±  SD from 
at least three different experiments. P < 0.05 was considered statistically significant. 
4. Conclusions 
Our results suggest that hypoxia or ROS can increase TLR10 expression in human monocytes and 
the transcriptional activities of NF-κB are mainly involved in this increase. Therefore, it is suggested 
that  ROS,  which  can  be  produced  by  various  exogenous  stimuli,  may  play  a  crucial  role  in  the 
regulation of expression and function of TLR10 as second messengers. 
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